Skip to content
MedsAcross

Medicine

Hydrochlorothiazide and Quinapril 12.5 mg/10 mg tablet

Available on requestPrescription onlyUS FDAGeneric name

Hydrochlorothiazide and Quinapril 12.5 mg/10 mg tablet is a generic prescription medicine for oral use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20–25° C (68–77° F).

Key facts

Active ingredient (INN)
Hydrochlorothiazide and Quinapril
Brand
Sold under the generic name
Strength
12.5 mg/10 mg
Dosage form
Tablet
Route
Oral
Packs
90 tablets, 500 tablets and 2 more
Manufacturers
LupinIndiaAurobindo PharmaIndiaCiplaIndiaChartwell RX
Origin register
US FDA, United States
Storage
Store at 20–25° C (68–77° F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
31 March 2004
Identifiers
RxCUI 310796, 310797, 310809DailyMed set ID 2eae533f-d0af-47e8-a1f2-94bc8cc89b5a, 50a58159-9572-4445-9859-b392632597da, 383ecaa6-29c8-4280-a442-c47f101d7c88 +1NDC 62135-667, 65862-161, 43386-710 +1Application ANDA076374, ANDA078450, ANDA201356

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
90 tablet, film coated in 1 bottle65862-161-90Aurobindo PharmaIndia24 August 2007
90 tablet in 1 bottle69097-828-05CiplaIndia20 July 2016
500 tablet in 1 bottle43386-710-05LupinIndia15 July 2011
90 tablet in 1 bottle43386-710-09LupinIndia15 July 2011
90 tablet in 1 bottle62135-667-90Chartwell RX5 December 2023

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 28 December 1999Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Hydrochlorothiazide and Quinapril

Clinical summary

Hydrochlorothiazide and Quinapril is a fixed-dose combination of an angiotensin converting enzyme inhibitor and a thiazide diuretic indicated for the treatment of hypertension, to lower blood pressure. It is available as tablets for oral use. MedsAcross supplies Hydrochlorothiazide and Quinapril for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Hydrochlorothiazide and Quinapril

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Hydrochlorothiazide and Quinapril 12.5 mg/10 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.